Long-term Tolerability
Long-Term Tolerability is the sustained capacity of a pharmacotherapeutic agent to be safely and acceptably used over an extended period in the management of Allergic Rhinitis, characterized by the absence of clinically significant adverse effects and maintenance of patient adherence.
220
Publications
12.9K
Citations
1.5K
Authors
726
Institutions
Publications per year
2017–2026
48
220
1–5 of 220
1.5K
University of North Carolina at Chapel Hill, United States
4 publications · 102 citations
4
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 1.5K
726
Inserm
Paris, France
7 h-index
41 publications
1.5K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
6 h-index
20 publications
4.2K citations
GlaxoSmithKline (United States)
Philadelphia, United States
5 h-index
13 publications
302 citations

University of Colorado Denver
Denver, United States
5 h-index
10 publications
602 citations

Research Triangle Park Foundation
Durham, United States
5 h-index
12 publications
255 citations
Novartis (Switzerland)
Basel, Switzerland
5 h-index
15 publications
1.2K citations
Massachusetts General Hospital
Boston, United States
5 h-index
26 publications
6.2K citations
Duke University
Durham, United States
4 h-index
4 publications
187 citations
1–8 of 726
Repository · 18 publications · 524 citations
14
h-index
ACAAI · 8 publications · 256 citations
8
h-index
7 publications · 842 citations
7
h-index
6 publications · 263 citations
6
h-index
4 publications · 358 citations
4
h-index
1–5